Sort
30,917 grants matching “tumor microenvironment”
Cancer Genomics: Integrative and Scalable Solutions in R/Bioconductor
$569,363Levi Waldron · Graduate School Of Public Health And Health Policy · U24 · FY2021 · CA
Adoptive T Cell Therapy for the Treatment of HER2 Overexpressing Cancers
$569,354Mary L. Disis · University Of Washington · R01 · FY2009 · CA
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
$569,307Susan M Kaech · Salk Institute For Biological Studies · R01 · FY2024 · CA
The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity
$569,184Arthur Hurwitz · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Investigating the Molecular Determinants Driving Response and Resistance to HDAC6 Targeted Therapy in Breast Cancer
$569,181Jose M Silva · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Targeting GRP94-TGF-beta Pathway for Cancer Immunotherapy
$569,160Zihai Li · Ohio State University · R01 · FY2021 · CA
The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity
$569,136Arthur Hurwitz · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
The Role of CD3z ITAM (Immunoreceptor Tyrosine-Based Activation Motif) diversity in CAR T cell Force and Function
$569,047Matthew Bettini · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
UCLA Tumor Immunology Institutional Traning Grant
$569,019Michael A Teitell · University Of California Los Angeles · T32 · FY2021 · CA
MRI Radiomic Signatures of DCIS to Optimize Treatment
$569,003Habibollah Rahbar · University Of Washington · R01 · FY2023 · CA
ONCOGENIC ROLE OF 3-MERCAPTOPYRUVATE SULFURTRANSFERASE IN ENDOTHELIAL CELLS OF THE TUMOR MICROENVIRONMENT
$568,800University Of Texas Medical Branch At Galveston · · FY2020 · Defense Health Agency
Tumor and host immune signatures associated with patient outcomes to GD2 chemoimmunotherapy in neuroblastoma
$568,722Kelly C Goldsmith · Emory University · R01 · FY2025 · CA
Lactate production by tumor associated macrophages promotes tumorigenesis
$568,686Lev Becker · University Of Chicago · R01 · FY2021 · CA
Modeling the role and regulation of reactive stroma in breast ductal carcinoma microinvasions
$568,661Katarzyna Anna Rejniak · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Focused ultrasound pre-conditioning for augmented nanoparticle penetration in infiltrative gliomas
$568,648Richard J Price · University Of Virginia · R01 · FY2024 · EB
Release of interleukin-1a as a mediator of immune evasion in cancer
$568,538Brian Ruffell · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
Tumor Endothelial Cell Regulation of Pro-Metastatic Fibrin Matrices
$568,496Chad V Pecot · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Tumor Endothelial Cell Regulation of Pro-Metastatic Fibrin Matrices
$568,496Chad V Pecot · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Innate lymphoid cell regulation of the host-microbiota interactions in cancer
$568,491Gregory F Sonnenberg · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Stimulation of Tumorigenesis by NKG2D
$568,459Thomas Spies · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA
Overcoming the immune-suppressive tumor microenvironment through in situ vaccination nanotechnology.
$568,456Nicole Franziska Steinmetz · University Of California, San Diego · U01 · FY2019 · CA
Cutaneous T cell lymphoma: a paradigm for dissecting susceptibility and resistance to checkpoint inhibition therapy
$568,426Christiane Querfeld · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
PROBING TUMOR MICROENVIRONMENT WITH IN VIVO PHAGE DISPLAY
$568,424Sanford Burnham Prebys Medical Discovery Institute · · FY2012 · Department of the Army
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
$568,413William C Hahn · Dana-Farber Cancer Inst · U01 · FY2021 · CA
A Phase II Clinical Trial in Newly Diagnosed Glioblastoma Patients Treated with WP1066 and Radiation
$568,219Amy Beth Heimberger · Northwestern University At Chicago · R01 · FY2024 · CA